Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Amicus Therapeutics Inc (NASDAQ: FOLD) was $5.99 for the day, down -2.28% from the previous closing price of $6.13. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 8.28 million shares were traded. FOLD stock price reached its highest trading level at $6.38 during the session, while it also had its lowest trading level at $5.97.
Ratios:
Our analysis of FOLD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1145.66. For the most recent quarter (mrq), Quick Ratio is recorded 2.29 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.
On December 13, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $17 to $12.
On September 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on September 06, 2024, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 19 ’25 when Campbell Bradley L sold 400 shares for $10.00 per share. The transaction valued at 4,000 led to the insider holds 1,150,657 shares of the business.
BRADLEY CAMPBELL bought 400 shares of FOLD for $3,940 on Feb 19 ’25. On Dec 02 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $10.02 each. As a result, the insider received 75,124 and left with 886,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 1844506624 and an Enterprise Value of 2080509952. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.23 while its Price-to-Book (P/B) ratio in mrq is 9.03. Its current Enterprise Value per Revenue stands at 3.831 whereas that against EBITDA is 37.14.
Stock Price History:
The Beta on a monthly basis for FOLD is 0.53, which has changed by -0.40575397 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, FOLD has reached a high of $12.65, while it has fallen to a 52-week low of $5.51. The 50-Day Moving Average of the stock is -1.33%, while the 200-Day Moving Average is calculated to be -28.37%.
Shares Statistics:
FOLD traded an average of 5.00M shares per day over the past three months and 4259780 shares per day over the past ten days. A total of 308.06M shares are outstanding, with a floating share count of 297.12M. Insiders hold about 3.51% of the company’s shares, while institutions hold 100.30% stake in the company. Shares short for FOLD as of 1752537600 were 21727135 with a Short Ratio of 4.35, compared to 1749772800 on 20898939. Therefore, it implies a Short% of Shares Outstanding of 21727135 and a Short% of Float of 7.1.
